Abstract
Ten children with chronic intractable asthma whose airway sensitivity had been established by means of inhalation challenges to specific antigens were hyposensitized over a period of 5 to 12 months. Five additional asthmatic children acted as “controls.” Various aqueous antigens were used both for immunotherapy and for inhalational challenges. Therapy was given uninterruptedly. The total dose varied from 1,000 to 8,000 protein nitrogen units (PNU) in the controls and from 30,000 to 230,000 PNU in the subjects. Repeat challenges in the low-dose “control” group showed no changes in bronchial sensitivity. Ten children who received high total dosage all showed decreased bronchial sensitivity to specific antigens. Three children who were under study for 12 months could be evaluated clinically as well as physiologically since all four seasons were covered. There was no evidence of clinical, physiologic, or medication improvement in any of them, despite significant decreases in bronchial sensitivity. High-dose therapy appeared to decrease bronchial sensitivity significantly in all except two subjects. The effect was not related to the antigen dose but appeared to be an individual response of the subject.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
